Page not found
Search results
-
Novartis Institutes for BioMedical Research (NIBR) Global Scholars Program
... Through this program, NIBR will support projects focused on novel science that can be translated to discovery research. Program ... All proposals must be reviewed by Vanderbilt Center for Technology Transfer and Commercialization (CTTC) before submission to NGSP. ...
sommers - 04/07/2023 - 12:30pm
-
How to Start a University Spinoff Biotech: From Concept to Commercialization
... Family Center for Applied Innovation and the Center for Technology Transfer & Commercialization present the next presentation from the ... He developed an RSV reverse genetics platform technology and novel strategies and methods for making vaccine candidates by synthetic ...
sommers - 04/03/2023 - 12:32pm
-
Vanderbilt and Deerfield Management celebrate Ancora Innovation, a collaboration for accelerating drug discovery, potential life-changing therapeutics
... cures for patients.” Vanderbilt’s Center for Technology Transfer and Commercialization within the Office of the Vice Provost ... resources from Deerfield, including projects to develop novel treatments for dystonia and other movement disorders , opioid use ...
sommers - 03/03/2023 - 1:30pm
-
Discovery of natural compound may help fend off antibiotic resistance of hard-to-treat infections
... professor of chemistry, has discovered a naturally occurring compound that is resilient to antibiotic resistance because of its rare ... bacteria. Bachmann is working with the Center for Technology Transfer and Commercialization to explore development for ...
sommers - 08/19/2020 - 6:47pm
-
Vanderbilt licenses compound to Nashville’s Appello to advance Parkinson’s therapies
... start-up Appello Pharmaceuticals, Inc. to advance novel compounds developed by researchers in the Vanderbilt Center for ...
sommers - 10/22/2018 - 2:54pm
-
Company co-founded by Vanderbilt professor receives distinguished FDA breakthrough device designation for minimally invasive surgical tool
... to doctors and patients. Such designations are granted to novel medical devices that have the potential to provide more effective ... conditions. EndoTheia’s device leverages foundational technology that was originally invented at Vanderbilt and the University of ...
sommers - 01/11/2023 - 10:03am
-
Vanderbilt-Ancora partnership advances research for rare form of epilepsy
... early development to identification of a clinically viable compound. The work, in conjunction with the Center for Technology Transfer and Commercialization , will continue to be led by C. ...
sommers - 10/31/2022 - 12:18pm
-
Center for Technology Transfer and Commercialization breaks records in leveraging innovation and discovery at Vanderbilt
... 10/10/2022 The Vanderbilt Center for Technology Transfer and Commercialization generated more than $100 million ... U.S. patents were issued. Among the issued patents include novel components needed to treat sickle cell disease and Parkinson’s disease, ...
sommers - 10/10/2022 - 10:35am
-
Oral administration of levocarnitine for treating Sjögren's Syndrome-associated dry eye
... Vanderbilt researchers have identified levocarnitine as a novel potential therapeutic for treating this condition. ... provide only temporary relief from symptoms. The proposed technology of oral levocarnitine administration offers a novel approach for ...
cttc_admin - 02/15/2024 - 1:31pm
-
Wolbachia genetic tools for population control of harmful insects
... that facilitates insect range expansion. Technology Overview Vanderbilt researchers have developed several ... cytoplasmic incompatibility. By inserting these genes and novel gene drivers directly into arthropods, the inventors have generated ...
cttc_admin - 02/15/2024 - 1:30pm